Search Results - "Call, Lee"

Refine Results
  1. 1
  2. 2

    Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome by Nayfach, Stephen, Páez-Espino, David, Call, Lee, Low, Soo Jen, Sberro, Hila, Ivanova, Natalia N., Proal, Amy D., Fischbach, Michael A., Bhatt, Ami S., Hugenholtz, Philip, Kyrpides, Nikos C.

    Published in Nature microbiology (01-07-2021)
    “…Bacteriophages have important roles in the ecology of the human gut microbiome but are under-represented in reference databases. To address this problem, we…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Probiotics and Human Milk Differentially Influence the Gut Microbiome and NEC Incidence in Preterm Pigs by Melendez Hebib, Valeria, Taft, Diana H, Stoll, Barbara, Liu, Jinxin, Call, Lee, Guthrie, Gregory, Jensen, Nick, Hair, Amy B, Mills, David A, Burrin, Douglas G

    Published in Nutrients (31-05-2023)
    “…Necrotizing enterocolitis (NEC) is the leading cause of death caused by gastrointestinal disease in preterm infants. Major risk factors include prematurity,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Illuminating the Virosphere Through Global Metagenomics by Call, Lee, Nayfach, Stephen, Kyrpides, Nikos C

    Published in Annual review of biomedical data science (20-07-2021)
    “…Viruses are the most abundant biological entity on Earth, infect cellular organisms from all domains of life, and are central players in the global biosphere…”
    Get full text
    Journal Article
  7. 7

    Metabolomic signatures distinguish the impact of formula carbohydrates on disease outcome in a preterm piglet model of NEC by Call, Lee, Stoll, Barbara, Oosterloo, Berthe, Ajami, Nadim, Sheikh, Fariha, Wittke, Anja, Waworuntu, Rosaline, Berg, Brian, Petrosino, Joseph, Olutoye, Oluyinka, Burrin, Douglas

    Published in Microbiome (19-06-2018)
    “…Major risk factors for necrotizing enterocolitis (NEC) include premature birth and formula feeding in the context of microbial colonization of the…”
    Get full text
    Journal Article
  8. 8

    Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors by Mollard, Alexis, Warner, Steven L, Call, Lee T, Wade, Mark L, Bearss, Jared J, Verma, Anupam, Sharma, Sunil, Vankayalapati, Hariprasad, Bearss, David J

    Published in ACS medicinal chemistry letters (08-12-2011)
    “…The receptor tyrosine kinase AXL has emerged in recent years as an potential oncology target due to its overexpression in several types of cancers coupled with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors by Chen, Ting, Sorna, Venkataswamy, Choi, Susie, Call, Lee, Bearss, Jared, Carpenter, Kent, Warner, Steven L., Sharma, Sunil, Bearss, David J., Vankayalapati, Hariprasad

    Published in Bioorganic & medicinal chemistry letters (15-12-2017)
    “…[Display omitted] In this work, we describe the use of the rule of 3 fragment-based strategies from biochemical screening data of 1100 in-house, small, low…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Abstract 4413: Mechanisms of sensitivity to treatment with the PDK1 inhibitors HCI-1680 and HCI-1708 by Walker, Brian, Venkataswamy, Sorna, Warner, Steven, Call, Lee, Vankayalapati, Hariprasad, Sharma, Sunil, Bearss, David J.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract The phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine kinase that has been considered a promising potential oncology drug target…”
    Get full text
    Journal Article
  17. 17

    Abstract 5543: Inhibition of the tyrosine kinase receptor Axl blocks cell invasion and promotes apoptosis in pancreatic cancer cells by Anderson, Malia, Ober, Alex, Mollard, Alexis, Call, Lee, Bearss, Jared J., Vankayalapati, Hariprasad, Sharma, Sunil, Warner, Steven, Bearss, David J.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Pancreatic cancer is virtually a uniformly lethal disease and a better understanding of the molecular basis of this malignancy is needed to discover…”
    Get full text
    Journal Article
  18. 18

    Abstract 3391: Overexpression of Nek2 promotes bortezomib resistance in multiple myeloma cells by Flory, Jessica, Brog, Rachel, Meng, Ling Yao, Call, Lee, Vankayalapati, Hariprasad, Tricot, Guido, Zhan, Fenghuang, Bearss, David J.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Drug resistance is a major complication in cancer therapy but the molecular mechanisms driving both innate and acquired drug resistance still remain…”
    Get full text
    Journal Article
  19. 19

    Abstract 1875: A novel series of metabolic activators of PKM2 alter oncogene-meditated changes in tumor cell metabolism by Bahr, Brigham L., Stevens, Jenny, Squire, Spencer, Moreno, Christopher, Call, Lee T., Stephens, Bret J., Mollard, Alexis, Warner, Steven L., Bearss, David J.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Rather than relying on oxidative phosphorylation for the generation of ATP, human tumor cells primarily utilize aerobic glycolysis to metabolize…”
    Get full text
    Journal Article
  20. 20

    Abstract 1368: Fragment-based design, synthesis and biological evaluation of a series of novel PDK1 inhibitors by Sharma, Sunil, Venkataswamy, Sorna, Warner, Steven L., Call, Lee T., Bearss, David J., Vankayalapati, Hariprasad

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract The PDK1 is a monomeric serine/threonine kinase and a promising oncology target of significant current interest for drug development due to its…”
    Get full text
    Journal Article